tert-Butyl 5-methoxy-1H-indole-3-carboxylate

Catalog No.: 
ACWZFQ789
CAS No.: 
1033265-55-2
Molecular Formula: 
C14H17NO3
Molecular Weight: 
247.29
tert-Butyl 5-methoxy-1H-indole-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$138.00InquiryInquiry
25g95%$683.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 5-methoxy-1H-indole-3-carboxylate
IUPAC Nametert-butyl 5-methoxy-1H-indole-3-carboxylate
MDL No.MFCD08272248
Molecular FormulaC14H17NO3
Molecular Weight247.29
SMILESCOC1=CC2=C(NC=C2C(=O)OC(C)(C)C)C=C1
InChI KeyRLUABYIWAMNZJD-UHFFFAOYSA-N
Synonymtert-butyl 5-Methoxyindole-3-carboxylate;5-Methoxy-1H-indole-3-carboxylic acid tert-butyl ester;tert-Butyl 5-Methoxy-1H-indole-3-carboxylate;1H-Indole-3-carboxylic acid, 5-methoxy-, 1,1-dimethylethyl ester
CAS No.1033265-55-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWZFQ789 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJXAF906 route compound structure diagram
    ACJXAF90610242-01-0In Stock
  4. Then
  5. ACWZFQ789 route product structure diagram
    ACWZFQ7891033265-55-2
Inquiry

2. ACWZFQ789 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWZFQ789 route product structure diagram
    ACWZFQ7891033265-55-2
Inquiry

3. ACWZFQ789 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWZFQ789 route product structure diagram
    ACWZFQ7891033265-55-2
Inquiry

Comments (0)